Compartilhar
Informação da revista
Vol. 37. Núm. 5.
Páginas 287-289 (Setembro - Outubro 2015)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Vol. 37. Núm. 5.
Páginas 287-289 (Setembro - Outubro 2015)
Scientific Comment
Open Access
The importance of hemoglobin A2 determination
Visitas
4391
Maria Stella Figueiredo
Autor para correspondência
stella.figueiredo@unifesp.br

Correspondence to: Hematology and Blood Transfusion Division, Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), Rua Dr. Diogo de Faria, 824, 0437-002 São Paulo, SP, Brazil.
Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
Este item recebeu

Under a Creative Commons license
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Tabelas (1)
Table 1. Causes of variation in the percentage of hemoglobin A2.
Texto Completo

Hemoglobin (Hb) A22δ2) constitutes less than 3% of the total hemoglobin (Hb) in adults and has almost no physiological importance.1 On the other hand, the determination of Hb A2 is an important tool to diagnose the beta-thalassemia trait (BTT).1,2 Although individuals with BTT do not need treatment, the accurate detection of the carrier state is important in genetic counseling to determine risk of having a child with a major disease.3

Elevated levels of Hb A2 and microcytosis are suggestive of the diagnosis of BTT. However, BTT may be present with normal levels of Hb A2 as a few cases of β-thalassemia are not associated with elevated Hb A2, and because of the association of BTT with iron deficiency or with α-thalassemia (α-Thal).1,2,4–6 There are many other factors, inherited or acquired, that can interfere in Hb A2 levels (Table 1).3,4

Table 1.

Causes of variation in the percentage of hemoglobin A2.

Hb A2  Inherited  Acquired 
Increased (>3.4%)  β-Thalassemia heterozygosityDeletional HPFH from Vietnamese/South East AsianHereditary high Hb A2Unstable hemoglobinSickle cell traitSickle cell anemia (particularly coexisting α-thalassemia)Hb S/β0-thalassemiaCongenital dyserythropoietic anemia (some cases)Heterozygosity for other β-chain variants  ThyrotoxicosisHIV infectionZidovudine therapyMegaloblastic anemia (some cases) 
Decreased (<2.2%)  α-thalassemia: α+ homozygosity, a0 heterozygosity, and HbH diseaseDeletional HPFH (except Vietnamese/South East Asian type)δβ and Aγδβ-thalassemia heterozygosity (some cases)δ-ThalassemiaHemoglobin LeporeHemoglobin Kenya  Severe iron deficiencyAnemia of chronic diseaseSideroblastic anemiaLead poisoningJuvenile myelomonocytic leukemiaAcquired Hb H diseaseAcute myeloid leukemia (some cases, particularly erythroleukemia)Aplastic anemia (some cases)HypothyroidismChemotherapy-induced increased Hb F synthesis 

Hb A2 – hemoglobin A2; HPFH: hereditary persistence of fetal hemoglobin; HIV: human immunodeficiency virus; HbH: hemoglobin H; Hb F: hemoglobin F or fetal hemoglobin.

Source: Modified from Bain et al.4

Hb A2 can be measured by several laboratorial methods, but these methods have differences in accuracy.7 Cation exchange high performance liquid chromatography (HPLC), microcolumn chromatography, and cellulose acetate electrophoresis with elution are considered acceptable methods to diagnose BTT, whereas cellulose acetate electrophoresis followed by scanning densitometry is not.2 The accuracy of cellulose acetate electrophoresis with elution depends on the training and experience of the laboratory technician who performs the test, and microcolumn chromatography can give problems with co-elution of some Hb variants.7

Recent studies have confirmed the higher quality of automated HPLC in the measurement of Hb A2 compared to the other methods,8,9 which is why this has become the method of choice. On the other hand, in automated HPLC, the measurement of Hb A2 is inaccurate when Hb S is present.2,3,10 As the amount of Hb S is related to the degree of inaccuracy, levels are higher in patients with sickle cell anemia (SCA) or Hb S/β-thalassemia (S-βThal) than in sickle cell trait.2 Thus, the amount of Hb A2 does not indicate BTT when Hb A and beta gene variants are found together.11 Furthermore, when beta gene variants are present without Hb A, the diagnosis of concomitant BTT is not necessarily associated to the elevation of Hb A2 and so further investigations using family studies or DNA analysis are necessary.10

As mentioned above, α-Thal is capable of interfering in the determination of Hb A2.4 Individuals with the α0-thalassemia trait or homozygous for α+-thalassemia have lower levels of Hb A2, but the influence of the coinheritance of α-Thal and BTT on Hb A2 levels is uncertain.6

In Brazil, the incidence of α-Thal varies from 0.11 to 0.22% depending on the geographical region studied.12–15 It is well known that the association of α-Thal and SCA is common in Brazil.16–18 Since SCA is considered a public health problem in Brazil and due to the clinical significance of α-Thal in respect to this anemia, diagnosis is important.19–21 However, diagnosis is mainly achieved by molecular techniques that are expensive and not easily accessible. It is also important to remember that the co-inheritance of α-Thal and SCA results in increased levels of Hb A2 as measured by automated HPLC, and could result in a misdiagnosis of S-βThal.4

There lies the importance of the paper entitled “Hemoglobin A2 values quantified by high performance liquid chromatography in patients with sickle cell disease, and the influence of the presence of alpha-thalassemia” written by Fonseca et al. and published in this edition of the Revista Brasileira de Hematologia e Hemoterapia.22 The authors demonstrate that Hb A2 was overestimated not only in individuals with Hb S but also in patients with Hb C, and that the Hb A2 level was influenced by the genotype of α-Thal.

In conclusion, in a country with a high degree of miscegenation such as Brazil, not only the diagnosis of double heterozygous states, such as S-βThal, but also the diagnosis of co-inheritance of SCA with α-Thal should be carried out carefully, taking into consideration the limitations of the available laboratory techniques. Family studies or DNA analysis, when possible, are desirable to confirm the correct diagnosis.

Conflicts of interest

The authors declare no conflicts of interest.

References
[1]
M.H. Steinberg, J.G. Adams.
Hemoglobin A2: origin, evolution, and aftermath.
Blood, 78 (1991), pp. 2165-2177
[2]
C.E. Head, M. Conroy, M. Jarvis, L. Phelan, B.J. Bain.
Some observations on the measurement of haemoglobin A2 and S percentages by high performance liquid chromatography in the presence and absence of alpha thalassaemia.
J Clin Pathol, 57 (2004), pp. 276-280
[3]
A. Giambona, C. Passarello, D. Renda, A. Maggio.
The significance of the hemoglobin A(2) value in screening for hemoglobinopathies.
Clin Biochem, 42 (2009), pp. 1786-1796
[4]
B.J. Bain, B.J. Wild, A.D. Stephens, L.A. Phelan.
Variant hemoglobins: a guide to identification.
1st ed., Wiley-Blackwell, (2010),
[5]
N. Saleh-Gohari, M. Khademi Bami, R. Nikbakht, H. Karimi-Maleh.
Effects of alpha-thalassaemia mutations on the haematological parameters of beta-thalassaemia carriers.
J Clin Pathol, 68 (2015), pp. 562-566
[6]
S. Denic, M.M. Agarwal, B. Al Dabbagh, A. El Essa, M. Takala, S. Showqi, et al.
Hemoglobin A2 lowered by iron deficiency and alpha-thalassemia: should screening recommendation for beta-thalassemia change?.
ISRN Hematol, 2013 (2013), pp. 858294
[7]
R.B. Colah, R. Surve, P. Sawant, E. D'Souza, K. Italia, S. Phanasgaonkar, et al.
HPLC studies in hemoglobinopathies.
Indian J Pediatr, 74 (2007), pp. 657-662
[8]
K. Anagnostopoulos, I. Tentes, C. Kalleas, D. Margaritis, A. Toli, D. Pendilas, et al.
Effect of HbS in the determination of HbA2 with the Menarini HA-8160 analyzer and comparison with other instruments.
Int J Lab Hematol, 31 (2009), pp. 665-672
[9]
R. Paleari, B. Gulbis, F. Cotton, A. Mosca.
Interlaboratory comparison of current high-performance methods for HbA2.
Int J Lab Hematol, 34 (2012), pp. 362-368
[10]
M. Shokrani, F. Terrell, E.A. Turner, M.D. Aguinaga.
Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin.
Ann Clin Lab Sci, 30 (2000), pp. 191-194
[11]
P.C. Giordano.
Editorial: measurement of HbA2.
Int J Lab Hematol, 34 (2012), pp. 335
[12]
A. Silva Cde, L.B. Baldim, G.C. Nhoncanse, F. Estevao Ida, D.G. Melo.
Neonatal screening for hemoglobinopathies in Sao Carlos, Sao Paulo, Brazil: analysis of a series of cases.
Rev Paul Pediatr, 33 (2015), pp. 19-27
[13]
G.H. de Medeiros Alcoforado, C.M. Bezerra, T.M. Araújo Moura Lemos, D.M. de Oliveira, E.M. Kimura, F. Ferreira Costa, et al.
Prevalence of alpha-thalassemia 3.7kb deletion in the adult population of Rio Grande do Norte, Brazil.
Genet Mol Biol, 35 (2012), pp. 594-598
[14]
S.C. Wagner, S.M. de Castro, T.P. Gonzalez, A.P. Santin, L. Filippon, C.F. Zaleski, et al.
Prevalence of common alpha-thalassemia determinants in south Brazil: importance for the diagnosis of microcytic anemia.
Genet Mol Biol, 33 (2010), pp. 641-645
[15]
E.V. Adorno, F.D. Couto, J.P. Moura Neto, J.F. Menezes, M. Rêgo, M.G. Reis, et al.
Hemoglobinopathies in newborns from Salvador, Bahia, Northeast Brazil.
Cad Saude Publica, 21 (2005), pp. 292-298
[16]
I.M. Lyra, M.S. Gonçalves, J.A. Braga, F. Gesteira Mde, M.H. Carvalho, S.T. Saad, et al.
Clinical, hematological, and molecular characterization of sickle cell anemia pediatric patients from two different cities in Brazil.
Cad Saude Publica, 21 (2005), pp. 1287-1290
[17]
M.S. Figueiredo, J. Kerbauy, M.S. Gonçalves, V.R. Arruda, S.T. Saad, M.F. Sonati, et al.
Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil.
[18]
G. De Lemos Cardoso, J.F. Guerreiro.
Molecular characterization of sickle cell anemia in the Northern Brazilian state of Para.
Am J Hum Biol, 22 (2010), pp. 573-577
[19]
R.B. de Paiva e Silva, A.S. Ramalho, R.M. Cassorla.
Sickle cell disease as a public health problem in Brazil.
Rev Saude Publica, 27 (1993), pp. 54-58
[20]
I.F. Domingos, D.A. Falcão, B.L. Hatzlhofer, A.F. Cunha, M.N. Santos, D.M. Albuquerque, et al.
Influence of the betas haplotype and alpha-thalassemia on stroke development in a Brazilian population with sickle cell anaemia.
Ann Hematol, 93 (2014), pp. 1123-1129
[21]
R.F. Camilo-Araujo, O.M. Amancio, M.S. Figueiredo, A.C. Cabanas-Pedro, J.A. Braga.
Molecular analysis and association with clinical and laboratory manifestations in children with sickle cell anemia.
Rev Bras Hematol Hemoter, 36 (2014), pp. 334-339
[22]
S.F. Fonseca, T. Amorim, A. Purificação, M.S. Goncalves, N. Boa-Sorte.
Hemoglobin A2 values quantified by high performance liquid chromatography in patients with sickle cell disease, and the influence of the presence of alpha-thalassemia.
Rev Bras Hematol Hemoter, 37 (2015), pp. 296-301

See paper by Fonseca et al. on pages 296–301.

Copyright © 2015. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
Idiomas
Hematology, Transfusion and Cell Therapy
Opções de artigo
Ferramentas